Group Integrative Breathwork for Chronic Pain
Group Breathwork Intervention for Chronic Pain
1 other identifier
interventional
35
1 country
1
Brief Summary
The aim of the proposed research is to iteratively develop, pilot test, and refine an integrative breathwork intervention that is suitable for group delivery to individuals with chronic pain. The intervention will be evaluated for feasibility, acceptability, and plausibility for clinically significant effects in people with chronic musculoskeletal pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Jun 2025
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedStudy Start
First participant enrolled
June 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedApril 9, 2026
April 1, 2026
9 months
May 6, 2025
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Treatment Acceptability
Treatment acceptability and satisfaction of the breathwork intervention will be measured using several face-valid items rated on a 10-point scale (1-10) where higher scores represent greater treatment acceptability and satisfaction.
Day 1
Change in Pain Intensity and Interference
The Pain, Enjoyment, and General Activities (PEG-3) scale will be used to assess pain intensity and pain interference over the past week on average.
Change from Baseline to 1-week follow-up, 1-month follow-up
Secondary Outcomes (15)
Patient's Global Impressions of Change
1-week follow-up, 1-month follow-up
Change in Pain Catastrophizing
Change from Baseline to 1-week follow-up, 1-month follow-up
Acute Treatment Effects
Day 1
Change in Pain Self-Efficacy
Change from Baseline to 1-month follow-up
Change in Sleep Disturbances
Change from Baseline to 1-week follow-up, 1-month follow-up
- +10 more secondary outcomes
Study Arms (1)
Integrative Breathwork Intervention
EXPERIMENTALThe breathwork intervention will be delivered in groups of 2-5 participants with chronic musculoskeletal pain. A conscious connected breathing technique will be engaged in for 45-60 minutes.
Interventions
The breathwork intervention involves a sustained conscious connected breathing pattern where there is no pause between inhale and exhale. During the breathing, a participant is guided to pay attention to the strongest sensation from moment-to-moment (e.g., mindfulness of somatic sensations) and relax unnecessary effort or tension. Participants lay supine throughout the 60 minute session. The session ends with spontaneous, relaxed breathing and an opportunity to briefly share one's experience.
Eligibility Criteria
You may qualify if:
- Men and women 18-70 years of age.
- Chronic musculoskeletal pain lasting for at least 3 months as a symptom of axial pain (e.g., back, neck) or limb pain (e.g., shoulder, knee, hip, wrist).
- Average pain intensity of ≥ 4/10 for the past month.
- Access to internet with a valid email address
- Able to lay down and stay relatively still for one hour.
You may not qualify if:
- Any suspicion of a medical (orthopedic, rheumatic or neurological) disease, that can fully explain the current level of severity of pain.
- Chronic pain possibly due to specific conditions (e.g., cancer, infection).
- Ongoing legal action or disability claim related to chronic pain.
- Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy, history of seizures) or moderate or severe symptoms from a previous brain injury, including stroke and traumatic brain injury.
- Respiratory disorder (e.g., chronic obstructive pulmonary disease) or moderate to severe asthma within the past 12 months.
- Activity limiting heart disease including cardiovascular or peripheral arterial disease.
- Uncontrolled hypertension (i.e. SBP/DBP of \> 160/95) or orthostatic hypotension (e.g., issues with fainting).
- Serious acute physical injuries or major surgery within the past 6 months.
- Serious psychiatric disorder (e.g., schizophrenia, panic disorder) or mental health issues requiring hospitalization within the past 12 months or currently on antipsychotic medications.
- History of hospitalization or treatment of substance use disorder within the past 12 months.
- Currently undergoing curative or palliative chemotherapy or radiation.
- Pregnant.
- Glaucoma or detached retina.
- Current participation or participation in the past 2 months of an interventional research study.
- Cognitive impairment or factors that would preclude comprehension of material and/or full participation in the study.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida Clinical Research Center
Gainesville, Florida, 32603, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2025
First Posted
May 18, 2025
Study Start
June 18, 2025
Primary Completion
March 18, 2026
Study Completion
March 31, 2026
Last Updated
April 9, 2026
Record last verified: 2026-04